PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
Scope & Guideline
Illuminating Pathways in Mental Health and Pharmacology
Introduction
Aims and Scopes
- Neurobiological Mechanisms in Psychiatric Disorders:
The journal emphasizes research that elucidates the neurobiological mechanisms underlying various psychiatric disorders, including depression, schizophrenia, bipolar disorder, and anxiety disorders. This includes studies on neurotransmitter systems, neuroinflammation, and neuroplasticity. - Pharmacological Interventions and Innovations:
A core focus is on the evaluation and development of pharmacological treatments for mental health disorders, including traditional medications and novel therapeutic approaches such as psychedelics and cannabinoids. - Translational Research:
The journal promotes translational research that connects basic neuroscience findings with clinical applications, aiming to bridge the gap between laboratory research and practical treatments in psychiatric care. - Psychobiotics and Gut-Brain Axis:
There is a growing interest in the role of the gut microbiome in mental health, with research exploring how psychobiotics and gut-brain interactions influence psychiatric conditions and treatment outcomes. - Neuroimaging and Biomarkers:
The use of neuroimaging techniques and biomarkers to understand psychiatric disorders is a significant focus, facilitating the identification of structural and functional brain changes associated with various mental health conditions.
Trending and Emerging
- Neuroinflammation as a Key Factor:
There is an increasing body of research focusing on the role of neuroinflammation in psychiatric disorders, highlighting its impact on disease progression and treatment response. - Psychedelic Research:
Research into the therapeutic potential of psychedelics for various psychiatric conditions is gaining momentum, with studies investigating their mechanisms of action and clinical efficacy. - Precision Medicine and Biomarkers:
The emphasis on precision medicine is growing, with a focus on identifying biomarkers that can predict treatment responses and personalize interventions for mental health disorders. - Gut-Brain Axis Research:
Emerging studies on the gut-brain axis are becoming increasingly prevalent, exploring how gut microbiota influence mental health and the implications for treatment strategies involving probiotics. - Machine Learning and AI in Psychiatry:
The incorporation of machine learning and artificial intelligence in analyzing neuroimaging and clinical data is on the rise, offering new insights into psychiatric disorders and enhancing diagnostic accuracy.
Declining or Waning
- Traditional Psychopharmacology:
There seems to be a waning emphasis on traditional psychopharmacological studies focusing solely on established medications, as the field shifts towards exploring novel compounds and integrative approaches. - Behavioral Studies without Biological Correlates:
Research that primarily investigates behavioral aspects of psychiatric disorders without linking them to biological or neurophysiological mechanisms is becoming less frequent, as the journal seeks more integrative studies. - Longitudinal Studies in Non-Clinical Populations:
There has been a noticeable reduction in the publication of longitudinal studies examining psychiatric symptoms in non-clinical populations, as the focus pivots towards more targeted clinical and translational research. - Single-Causal Pathway Studies:
Research that explores single-causal pathways for psychiatric disorders is less common now; there is a shift towards understanding complex interactions and multi-factorial models.
Similar Journals
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
Fostering collaboration in the pursuit of psychiatric advancements.INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE is a distinguished publication in the field of Psychiatry and Mental Health, published by TAYLOR & FRANCIS LTD in the United Kingdom. With an impressive 2023 impact factor that places it in the Q2 category among its peers, this journal is an essential resource for researchers, clinicians, and students dedicated to advancing mental health practices and understanding psychiatric disorders. Covering topics from clinical studies to innovative treatment methodologies, the journal welcomes original research, reviews, and case studies that contribute valuable insights into clinical practice. Accessible without any open access restrictions, the journal has been a pivotal platform since its inception in 1997, facilitating knowledge exchange in the field up to 2024. As evidenced by its notable Scopus ranking within the top 73rd percentile of Psychiatry and Mental Health, it remains committed to impacting clinical practices significantly.
ACTAS ESPANOLAS DE PSIQUIATRIA
Elevating psychiatric discourse through quality research.ACTAS ESPANOLAS DE PSIQUIATRIA, published by the renowned JUAN JOSE LOPEZ-IBOR FOUNDATION, serves as a vital resource in the field of psychiatry and mental health, particularly within the Spanish-speaking academic community. With its ISSN 1139-9287 and E-ISSN 1578-2735, this journal has been a critical platform for disseminating high-quality research since its inception in 1996 and continues to contribute valuable insights until 2024. As a recognized journal in the Q3 category of psychiatry and mental health, it ranks 387 out of 567 in Scopus, placing it within the 31st percentile, thereby indicating a growing influence among its peers. The journal’s open access options enhance its accessibility, encouraging a broader readership to engage with contemporary research issues in mental health. Researchers, professionals, and students alike will find ACTAS ESPANOLAS DE PSIQUIATRIA essential for staying informed on the latest developments and innovations in psychiatric practice and research.
Brazilian Journal of Psychiatry
Elevating psychiatric discourse for a healthier future.The Brazilian Journal of Psychiatry is a prominent peer-reviewed journal dedicated to advancing the field of psychiatry and mental health, published by the Associação Brasileira de Psiquiatria. With an impressive Q2 ranking in the Psychiatry and Mental Health category for 2023 and a Scopus rank of #130 out of 567, this journal serves as a vital resource for researchers, clinicians, and students alike. Since its transition to Open Access in 1999, it has aimed to disseminate high-quality research, innovative practices, and critical insights relevant to mental health in Brazil and beyond. The journal's focus spans various topics in psychiatry, aiming to bridge the gap between research and clinical application, making it essential reading for professionals and academicians committed to improving mental health outcomes. With a commitment to fostering scholarly discourse, the Brazilian Journal of Psychiatry not only enriches the academic landscape but also enhances the practice of psychiatry through its widespread accessibility and dedication to excellence in research.
Cognitive Neuropsychiatry
Decoding the Mind: Uniting Neuroscience and Clinical PracticeCognitive Neuropsychiatry is a distinguished academic journal published by Routledge Journals, Taylor & Francis Ltd, dedicated to the intersection of cognitive neuroscience and psychiatry. With a strong commitment to advancing knowledge in these rapidly evolving fields, this journal provides a platform for high-quality, peer-reviewed research that explores cognitive processes underlying psychiatric disorders. Aiming to bridge gaps between neuroscience and clinical practice, it serves as an essential resource for researchers, professionals, and students alike. As evidenced by its performance metrics, the journal ranks in the Q2 quartile for Psychiatry and Mental Health, and Q3 for Cognitive Neuroscience, showcasing its relevance and growing impact, particularly among a competitive audience. While it does not currently offer open access options, Cognitive Neuropsychiatry remains a vital outlet for disseminating impactful findings, offering insights that shape contemporary psychiatric understanding and interventions.
NEUROPSYCHOBIOLOGY
Transforming Understanding: The Intersection of Neuroscience and PsychologyNEUROPSYCHOBIOLOGY, published by KARGER, is a leading academic journal that has been at the forefront of exploring the intricate relationships between neuroscience and psychological processes since its inception in 1975. With both an ISSN of 0302-282X and an E-ISSN of 1423-0224, the journal is renowned for its rigorous peer-reviewed articles and significant contributions to the fields of Biological Psychiatry, Neuropsychology, and Physiological Psychology. Its impact is reflected in its esteemed Scopus rankings, standing out in the 92nd and 81st percentiles in their respective categories. With a commitment to advancing understanding in mental health and neurological science, NEUROPSYCHOBIOLOGY is classified in the Q3 and Q1 quartiles, making it a vital resource for researchers, clinicians, and students alike. Based in Switzerland, the journal embraces a holistic approach to psychological research, bridging gaps between theoretical frameworks and practical applications, thus promoting impactful advancements in the understanding of the human mind.
Explore the latest findings and theories with NEUROPSYCHOBIOLOGY, where your work can contribute to the evolving landscape of neuropsychological studies.
PSYCHIATRY RESEARCH-NEUROIMAGING
Transforming Psychiatric Research Through Innovative ImagingPSYCHIATRY RESEARCH-NEUROIMAGING, published by Elsevier Ireland Ltd, stands at the intersection of neuroscience, psychiatry, and medical imaging, specializing in the latest advancements in neuroimaging techniques and their applications in psychiatric research. With a robust history since 1990, this esteemed journal features original research, reviews, and case studies that contribute significantly to the understanding of brain function in mental health disorders. Holding a notable Impact Factor and classified in Q2 for the fields of Neuroscience and Psychiatry and Q1 for Radiology, it serves as a vital resource for scholars and practitioners seeking to advance their knowledge in these domains. The journal is indexed in major databases, enhancing visibility and accessibility for global researchers. While it currently does not follow an open-access model, its reputable standing in Scopus ranks, alongside its targeted scope, makes it indispensable for those invested in neuroimaging research and its implications in psychiatry.
Noropsikiyatri Arsivi-Archives of Neuropsychiatry
Advancing the Frontiers of NeuropsychiatryNoropsikiyatri Arsivi-Archives of Neuropsychiatry is a prominent scholarly journal dedicated to advancing knowledge in the fields of neuropsychiatry and mental health. Published by the Turkish Neuropsychiatry Association, this journal aims to disseminate high-quality research that contributes to a deeper understanding of psychiatric disorders, innovative treatment modalities, and interdisciplinary approaches in neuroscience. Based in Turkey, the journal has been in circulation since its inception, with a rich history reflecting its commitment to addressing contemporary issues in mental health care. It is currently indexed under Scopus, with notable rankings in both Psychiatry and Mental Health (Rank #378/567, 33rd Percentile) and General Neuroscience (Rank #97/113, 14th Percentile), highlighting its increasing relevance and impact in the academia. Although it is not currently an open access journal, its contributions remain vital for researchers, professionals, and students who wish to stay abreast of the latest developments and research in neuropsychiatry.
Iranian Journal of Psychiatry and Behavioral Sciences
Fostering Evidence-Based Practices in PsychiatryIranian Journal of Psychiatry and Behavioral Sciences, published by BRIEFLAND, is a pivotal platform for scholars and practitioners in the fields of psychiatry and behavioral sciences. With its ISSN 1735-8639 and E-ISSN 1735-9287, this journal primarily caters to the Iranian context while fostering a global dialogue on contemporary issues in mental health, behavioral neurology, and biological psychiatry. Since its inception in 2007, the journal has committed to disseminating high-quality research and reviews, thereby contributing to its categorization in the fourth quartile (Q4) for both Behavioral Neuroscience and Biological Psychiatry as of 2023. Although currently lacking an open access model, the journal's accessibility to critical research discussions is vital for enhancing knowledge among researchers, professionals, and students alike. With emerging relevance in the Iranian mental health landscape, it aims to bridge gaps in understanding and promote evidence-based practices from 2007 to 2024 and beyond.
COMPREHENSIVE PSYCHIATRY
Bridging research and practice in contemporary psychiatry.COMPREHENSIVE PSYCHIATRY is a leading peer-reviewed journal dedicated to advancing the field of psychiatry and mental health, published by W B SAUNDERS CO-ELSEVIER INC. With its Q1 designation in both Clinical Psychology and Psychiatry and Mental Health, this journal ranks impressively, holding the 9th position out of 311 in Clinical Psychology and the 27th position out of 567 in Psychiatry and Mental Health according to Scopus metrics. Since transitioning to Open Access in 2019, COMPREHENSIVE PSYCHIATRY has significantly increased its accessibility, enabling a broader audience of researchers, mental health professionals, and students to engage with cutting-edge research and clinical practices. The journal's scope encompasses a wide array of topics, including but not limited to evidence-based interventions, psychological evaluations, and the latest empirical studies in the field. As we continue to navigate the complexities of mental health in contemporary society, this journal serves as a vital resource for disseminating impactful findings and fostering collaborative discourse among scholars and practitioners globally.
PSYCHIATRIC GENETICS
Illuminating the Genetic Basis of Psychiatric ConditionsPSYCHIATRIC GENETICS, published by LIPPINCOTT WILLIAMS & WILKINS, is a pivotal journal dedicated to the interdisciplinary study of genetic factors in psychiatric disorders, bridging the fields of genetics, psychiatry, and neuroscience. With a commitment to advancing research from its inception in 1990 and continuing through 2024, the journal provides a platform for innovative studies and findings that explore the genetic underpinnings of mental health. Although not currently an Open Access publication, it reaches a wide audience concerned with the complex interplay between genetics and psychiatric conditions, contributing to its Q3 and Q2 quartile rankings across multiple relevant categories in 2023. The importance of this journal cannot be understated; it serves as a crucial resource for researchers, clinicians, and students eager to uncover insights that could lead to more effective interventions and treatments in the realm of mental health.